Amiodarone and the thyroid

Shehzad Basaria, David S Cooper

Research output: Contribution to journalArticle

Abstract

Among the drugs affecting the thyroid gland, no drug has puzzled, and at the same time fascinated, endocrinologists more than amiodarone. Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties. It is very rich in iodine, with a 100-mg tablet containing an amount of iodine that is 250 times the recommended daily iodine requirement. Amiodarone produces characteristic alterations in thyroid function tests in euthyroid patients. Understanding these alterations is crucial in avoiding unnecessary investigations and treatment. Amiodarone-induced thyroid dysfunction occurs because of both its iodine content and the direct toxic effects of the compound on thyroid parenchyma. Amiodarone-induced hyperthyroidism is more common in iodine-deficient regions of the world, whereas amiodarone-induced hypothyroidism is usually seen in iodine-sufficient areas. In contrast to amiodarone-induced hypothyroidism, amiodarone-induced thyrotoxicosis is a difficult condition to diagnose and treat. In this review, we discuss the alterations in thyroid function tests seen in euthyroid subjects, the epidemiology and mechanism of amiodarone-induced thyroid dysfunction, treatment options available, and the consequences of amiodarone use in pregnancy and lactation; and finally, we propose a follow-up strategy in patients taking amiodarone.

Original languageEnglish (US)
Pages (from-to)706-714
Number of pages9
JournalAmerican Journal of Medicine
Volume118
Issue number7
DOIs
StatePublished - Jul 2005

Fingerprint

Amiodarone
Thyroid Gland
Iodine
Thyroid Function Tests
Hypothyroidism
Pharmaceutical Preparations
Thyrotoxicosis
Poisons
Anti-Arrhythmia Agents
Hyperthyroidism
Lactation
Tablets
Epidemiology

Keywords

  • Amiodarone
  • Hyperthyroidism
  • Hypothyroidism
  • Lactation
  • Pregnancy
  • Thyroiditis

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Amiodarone and the thyroid. / Basaria, Shehzad; Cooper, David S.

In: American Journal of Medicine, Vol. 118, No. 7, 07.2005, p. 706-714.

Research output: Contribution to journalArticle

Basaria, Shehzad ; Cooper, David S. / Amiodarone and the thyroid. In: American Journal of Medicine. 2005 ; Vol. 118, No. 7. pp. 706-714.
@article{d6e06ca87dfe4f99bc0e714fb8714aca,
title = "Amiodarone and the thyroid",
abstract = "Among the drugs affecting the thyroid gland, no drug has puzzled, and at the same time fascinated, endocrinologists more than amiodarone. Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties. It is very rich in iodine, with a 100-mg tablet containing an amount of iodine that is 250 times the recommended daily iodine requirement. Amiodarone produces characteristic alterations in thyroid function tests in euthyroid patients. Understanding these alterations is crucial in avoiding unnecessary investigations and treatment. Amiodarone-induced thyroid dysfunction occurs because of both its iodine content and the direct toxic effects of the compound on thyroid parenchyma. Amiodarone-induced hyperthyroidism is more common in iodine-deficient regions of the world, whereas amiodarone-induced hypothyroidism is usually seen in iodine-sufficient areas. In contrast to amiodarone-induced hypothyroidism, amiodarone-induced thyrotoxicosis is a difficult condition to diagnose and treat. In this review, we discuss the alterations in thyroid function tests seen in euthyroid subjects, the epidemiology and mechanism of amiodarone-induced thyroid dysfunction, treatment options available, and the consequences of amiodarone use in pregnancy and lactation; and finally, we propose a follow-up strategy in patients taking amiodarone.",
keywords = "Amiodarone, Hyperthyroidism, Hypothyroidism, Lactation, Pregnancy, Thyroiditis",
author = "Shehzad Basaria and Cooper, {David S}",
year = "2005",
month = "7",
doi = "10.1016/j.amjmed.2004.11.028",
language = "English (US)",
volume = "118",
pages = "706--714",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Amiodarone and the thyroid

AU - Basaria, Shehzad

AU - Cooper, David S

PY - 2005/7

Y1 - 2005/7

N2 - Among the drugs affecting the thyroid gland, no drug has puzzled, and at the same time fascinated, endocrinologists more than amiodarone. Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties. It is very rich in iodine, with a 100-mg tablet containing an amount of iodine that is 250 times the recommended daily iodine requirement. Amiodarone produces characteristic alterations in thyroid function tests in euthyroid patients. Understanding these alterations is crucial in avoiding unnecessary investigations and treatment. Amiodarone-induced thyroid dysfunction occurs because of both its iodine content and the direct toxic effects of the compound on thyroid parenchyma. Amiodarone-induced hyperthyroidism is more common in iodine-deficient regions of the world, whereas amiodarone-induced hypothyroidism is usually seen in iodine-sufficient areas. In contrast to amiodarone-induced hypothyroidism, amiodarone-induced thyrotoxicosis is a difficult condition to diagnose and treat. In this review, we discuss the alterations in thyroid function tests seen in euthyroid subjects, the epidemiology and mechanism of amiodarone-induced thyroid dysfunction, treatment options available, and the consequences of amiodarone use in pregnancy and lactation; and finally, we propose a follow-up strategy in patients taking amiodarone.

AB - Among the drugs affecting the thyroid gland, no drug has puzzled, and at the same time fascinated, endocrinologists more than amiodarone. Amiodarone is a potent class III anti-arrhythmic drug that also possesses beta-blocking properties. It is very rich in iodine, with a 100-mg tablet containing an amount of iodine that is 250 times the recommended daily iodine requirement. Amiodarone produces characteristic alterations in thyroid function tests in euthyroid patients. Understanding these alterations is crucial in avoiding unnecessary investigations and treatment. Amiodarone-induced thyroid dysfunction occurs because of both its iodine content and the direct toxic effects of the compound on thyroid parenchyma. Amiodarone-induced hyperthyroidism is more common in iodine-deficient regions of the world, whereas amiodarone-induced hypothyroidism is usually seen in iodine-sufficient areas. In contrast to amiodarone-induced hypothyroidism, amiodarone-induced thyrotoxicosis is a difficult condition to diagnose and treat. In this review, we discuss the alterations in thyroid function tests seen in euthyroid subjects, the epidemiology and mechanism of amiodarone-induced thyroid dysfunction, treatment options available, and the consequences of amiodarone use in pregnancy and lactation; and finally, we propose a follow-up strategy in patients taking amiodarone.

KW - Amiodarone

KW - Hyperthyroidism

KW - Hypothyroidism

KW - Lactation

KW - Pregnancy

KW - Thyroiditis

UR - http://www.scopus.com/inward/record.url?scp=21244452633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244452633&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2004.11.028

DO - 10.1016/j.amjmed.2004.11.028

M3 - Article

C2 - 15989900

AN - SCOPUS:21244452633

VL - 118

SP - 706

EP - 714

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 7

ER -